Telix Pharmaceuticals |
High $11.49 |
Low $11.20 |
Trades 4,718 |
Turnover $7,499,551 |
Volume 664,557 |
| 30 June 2023 at 4:12pm | ||||
|
Market Cap (14-Nov) $4,655,044,608 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (9-Nov) 35,408,995 (10.40%) (16th) |
|
52w High $18.22 |
52w Low $8.26 |
P/E 178.57 |
EPS 0.15 |
Cleansing Notice
TLX released this announcement to the ASX on 30 December 2022, 8:24. The announcement is not marked as price sensitive, and is 1 page(s) in length and 143.39kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 1.667% short sold according to ASIC data. It was ranked the 140th most shorted stock on the ASX. It is now ranked as the 16th most shorted stock on the ASX with 10.404% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Cleansing Notice | 30 December 2022, 8:24 |
| Application for quotation of securities - TLX | 30 December 2022, 8:24 |
| ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU | 22 December 2022, 8:25 |
| Cleansing Notice | 19 December 2022, 13:22 |
If you were already registered, log in here.